WARMINSTER, Pa. (AP) _ Arbutus Biopharma Corp. (ABUS) on Thursday reported a loss of $21.3 million in its fourth quarter.

The Warminster, Pennsylvania-based company said it had a loss of 15 cents per share.

The biopharmaceutical company posted revenue of $3.2 million in the period.

For the year, the company reported that its loss widened to $76.2 million, or 83 cents per share. Revenue was reported as $11 million.

The company's shares closed at $3.09. A year ago, they were trading at $3.83.

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ABUS at https://www.zacks.com/ap/ABUS

Copyright by Automated Insights, Inc. All rights reserved., source Associated Press News